{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:07:34Z","timestamp":1793236054476,"version":"4.5.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Objective<\/jats:bold><jats:bold>:<\/jats:bold> Our study aims to summarize and analyze the clinical characteristics of transient infantile hypertriglyceridemia (HTGTI) and variants in the glycerol-3-phosphate dehydrogenase 1 (<jats:italic>GPD1<\/jats:italic>) gene and the effect of HTGTI on the protein structure of <jats:italic>GPD1<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Retrospective analysis, using the general data, symptoms, signs, and auxiliary examinations, was performed on patients with HTGTI, which were confirmed by genetic testing in our hospital and reported cases online. The clinical data were analyzed using statistical and bioinformatic approaches.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 31 genetically confirmed HTGTI patients were collected from our hospital and cases reported in the literature. The clinical manifestations showed the median age of onset was 6.0 (1.9, 12.0) months. All the patients had normal psychiatric status, but 22.6% of them presented growth retardation and short stature, 93.5% had hepatomegaly, and 16.1% had splenomegaly. Just a few children were reported with jaundice, cholestasis, and obesity (3.2\u20136.5%). The laboratory investigations showed that 96.8% of them had hypertriglyceridemia (HTG) with a median level of 3.1 (2.1, 5.5) mmol\/L, but only 30.0% had returned to normal during follow-up. In addition, 93.5% of patients had elevated alanine aminotransferase (ALT) with an average level of 92.1 \u00b1 43.5 U\/L, while 38.7% had hypercholesterolemia. Upon abdominal imaging, all patients presented fatty liver and liver steatosis, with 66.7% of patients showing hepatic fibrosis. Statistical differences in triglyceride (TG) level were observed in the \u22646\u00a0months group compared with the older groups and in the 13\u00a0months to 6\u00a0years group with &amp;gt;6\u00a0years group (<jats:italic>H<\/jats:italic> = 22.02, <jats:italic>P<\/jats:italic> &amp;lt; 0.05). The restricted cubic spline model showed that severe HTG decreased in the early stage of infants to the normal level; however, it rebounded again to a mild or moderate level after the following days. The genetic test revealed that the main variant types of the <jats:italic>GPD1<\/jats:italic> gene were missense variants (51.6%), followed by splicing variants (35.5%) and nonsense variants (12.9%). Of patients, 87.1% had homozygous variants, with the most frequent loci being c.361-1G &amp;gt; C and c.895G &amp;gt; A.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The common manifestations of HTGTI were HTG, hepatomegaly, elevated liver transaminases, and hepatic steatosis in early infancy. However, the recurrence of aberrant HTG may pose long-term detrimental effects on HTGTI patients.<\/jats:p>","DOI":"10.3389\/fgene.2022.916672","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T05:17:22Z","timestamp":1660627042000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical characteristics and variant analyses of transient infantile hypertriglyceridemia related to GPD1 gene"],"prefix":"10.3389","volume":"13","author":[{"given":"Jun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianying","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farooq","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1172\/JCI112332","article-title":"Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients","volume":"77","author":"Baggio","year":"1986","journal-title":"J. Clin. Invest."},{"key":"B3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ajhg.2011.11.028","article-title":"Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1","volume":"90","author":"Basel-Vanagaite","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: An endocrine society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMcp070061","article-title":"Hypertriglyceridemia","volume":"357","author":"Brunzell","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/s0002-9149(00)01127-9","article-title":"Evidence that triglycerides are an independent coronary heart disease risk factor","volume":"86","author":"Cullen","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10545-016-9956-7","article-title":"Expanding the molecular diversity and phenotypic spectrum of glycerol 3-phosphate dehydrogenase 1 deficiency","volume":"39","author":"Dionisi-Vici","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/biomedicines9091078","article-title":"Treatment of dyslipidaemia in children","volume":"9","author":"Fiorentino","year":"2021","journal-title":"Biomedicines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: Implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes & Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1172\/JCI115229","article-title":"Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin","volume":"87","author":"Henderson","year":"1991","journal-title":"J. Clin. Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.celrep.2016.03.020","article-title":"Tumor-induced hyperlipidemia contributes to tumor growth","volume":"15","author":"Huang","year":"2016","journal-title":"Cell Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/ng.628","article-title":"Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia","volume":"42","author":"Johansen","year":"2010","journal-title":"Nat. Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/ejhg.2014.8","article-title":"A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia","volume":"22","author":"Joshi","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1093\/hmg\/ddg255","article-title":"A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia","volume":"12","author":"Kao","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12098-021-03663-2","article-title":"Transient infantile hypertriglyceridemia and hepatic steatosis in an infant with GPD1 mutation","volume":"88","author":"Kumar","year":"2021","journal-title":"Indian J. Pediatr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur. Heart J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1210\/er.2014-1062","article-title":"Hypertriglyceridemia in the genomic era: A new paradigm","volume":"36","author":"Lewis","year":"2015","journal-title":"Endocr. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12876-018-0827-6","article-title":"A novel homozygous mutation in the glycerol-3-phosphate dehydrogenase 1 gene in a Chinese patient with transient infantile hypertriglyceridemia: A case report","volume":"18","author":"Li","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1002\/ajmg.a.38473","article-title":"Biallelic mutations in GPD1 gene in a Chinese boy mainly presented with obesity, insulin resistance, fatty liver, and short stature","volume":"173","author":"Li","year":"2017","journal-title":"Am. J. Med. Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"726116","DOI":"10.3389\/fgene.2021.726116","article-title":"Case report: Identification of a novel homozygous mutation in GPD1 gene of a Chinese child with transient infantile hypertriglyceridemia","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/bioinformatics\/btv362","article-title":"IBS: An illustrator for the presentation and visualization of biological sequences: Fig. 1","volume":"31","author":"Liu","year":"2015","journal-title":"BIOINFORMATICS"},{"key":"B23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5551\/jat.44537","article-title":"A compound heterozygous mutation of lipase maturation factor 1 is responsible for hypertriglyceridemia of a patient","volume":"26","author":"Liu","year":"2019","journal-title":"Jat"},{"key":"B24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jmd2.12125","article-title":"Successful fenofibrate therapy for severe and persistent hypertriglyceridemia in a boy with cirrhosis and glycerol\u20103\u2010phosphate dehydrogenase 1 deficiency","volume":"54","author":"Matarazzo","year":"2020","journal-title":"JIMD Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jmb.2005.12.074","article-title":"Crystal structures of human glycerol 3-phosphate dehydrogenase 1 (GPD1)","volume":"357","author":"Ou","year":"2006","journal-title":"J. Mol. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fendo.2020.00252","article-title":"Causes and consequences of hypertriglyceridemia","volume":"11","author":"Packard","year":"2020","journal-title":"Front. Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3238\/arztebl.2019.0825","article-title":"The diagnosis and treatment of hypertriglyceridemia","volume":"116","author":"Parhofer","year":"2019","journal-title":"Dtsch. Arztebl Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/ng.2007.24","article-title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia","volume":"39","author":"P\u00e9terfy","year":"2007","journal-title":"Nat. Genet."},{"key":"B29","article-title":"Genetic disorders causing hypertriglyceridemia in children and adolescents","volume-title":"Endotext","author":"Shah","year":"2020"},{"key":"B30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12098-020-03385-x","article-title":"GPD1 deficiency - underdiagnosed cause of liver disease","volume":"88","author":"Tesarova","year":"2021","journal-title":"Indian J. Pediatr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1542\/pir.2016-0138","article-title":"Approach to hypertriglyceridemia in the pediatric population","volume":"38","author":"Valaiyapathi","year":"2017","journal-title":"Pediatr. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1476-511X-6-23","article-title":"Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650)","volume":"6","author":"Wang","year":"2007","journal-title":"Lipids Health Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e25697","DOI":"10.1097\/MD.0000000000025697","article-title":"Transient infantile hypertriglyceridemia with jaundice","volume":"100","author":"Wang","year":"2021","journal-title":"Med. Baltim."},{"key":"B34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3760\/cma.j.cn112140-20200411-00375","article-title":"Transient infantile hypertriglyceridemia caused by GPD1 deficiency: Report of two cases and literature review","volume":"58","author":"Xie","year":"2020","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B35","doi-asserted-by":"publisher","first-page":"774846","DOI":"10.3389\/fgene.2021.774846","article-title":"Use ggbreak to effectively utilize plotting space to deal with large datasets and outliers","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Genet."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.916672\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T05:17:32Z","timestamp":1660627052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.916672\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":35,"alternative-id":["10.3389\/fgene.2022.916672"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.916672","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"article-number":"916672"}}